Advertisement

Topics

Cambrex invests $24 Million in new highly potent API manufacturing capacity at its Charles City, Iowa facility. The plant manufactures a range of APIs and pharmaceutical intermediates, including highly potent molecules and controlled substances.
Contributed Author: 
Cambrex Corporation

Original Article: Cambrex Invests $24M to Expand API Manufacturing Capacity

NEXT ARTICLE

More From BioPortfolio on "Cambrex Invests $24M to Expand API Manufacturing Capacity"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search
Advertisement
 

News Quicklinks